Early clinical trials of chemopreventive and biologic agents: Designs, populations, and endpoints. [electronic resource]
- Urology Apr 2001
- 216-9 p. digital
Publication Type: Journal Article
1527-9995
10.1016/s0090-4295(00)00978-x doi
Anticarcinogenic Agents--pharmacology Clinical Trials as Topic--methods Clinical Trials, Phase I as Topic Clinical Trials, Phase II as Topic Drug Interactions Drug Screening Assays, Antitumor--methods Flurbiprofen--therapeutic use Humans Male Prostatic Neoplasms--prevention & control Research Design